These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 36011286

  • 1. miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line.
    Kaur R, Kanthaje S, Taneja S, Dhiman RK, Chakraborti A.
    Genes (Basel); 2022 Aug 01; 13(8):. PubMed ID: 36011286
    [Abstract] [Full Text] [Related]

  • 2. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
    Jing Z, Ye X, Ma X, Hu X, Yang W, Shi J, Chen G, Gong L.
    Cancer Med; 2020 Jun 01; 9(12):4324-4338. PubMed ID: 32324343
    [Abstract] [Full Text] [Related]

  • 3. Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma.
    Kumar M, Kaur R, Kanthaje S, Dhiman RK, Chakraborti A.
    J Cancer Res Clin Oncol; 2023 Aug 01; 149(9):5823-5839. PubMed ID: 36583742
    [Abstract] [Full Text] [Related]

  • 4. MiR-375 attenuates sorafenib resistance of hepatocellular carcinoma cells by inhibiting cell autophagy.
    Wang D, Yang J.
    Acta Biochim Pol; 2023 Apr 17; 70(2):239-246. PubMed ID: 37068178
    [Abstract] [Full Text] [Related]

  • 5. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
    Lin Z, Xia S, Liang Y, Ji L, Pan Y, Jiang S, Wan Z, Tao L, Chen J, Lin C, Liang X, Xu J, Cai X.
    Theranostics; 2020 Apr 17; 10(19):8834-8850. PubMed ID: 32754282
    [Abstract] [Full Text] [Related]

  • 6. PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib.
    Zhang K, Chen J, Zhou H, Chen Y, Zhi Y, Zhang B, Chen L, Chu X, Wang R, Zhang C.
    Cell Death Dis; 2018 Feb 22; 9(3):312. PubMed ID: 29472524
    [Abstract] [Full Text] [Related]

  • 7. MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1.
    Dong ZB, Wu HM, He YC, Huang ZT, Weng YH, Li H, Liang C, Yu WM, Chen W.
    Cell Death Dis; 2022 Jan 10; 13(1):35. PubMed ID: 35013144
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway.
    Li TT, Mou J, Pan YJ, Huo FC, Du WQ, Liang J, Wang Y, Zhang LS, Pei DS.
    J Biomed Sci; 2021 Aug 02; 28(1):56. PubMed ID: 34340705
    [Abstract] [Full Text] [Related]

  • 9. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
    Li W, Dong X, He C, Tan G, Li Z, Zhai B, Feng J, Jiang X, Liu C, Jiang H, Sun X.
    J Exp Clin Cancer Res; 2019 May 03; 38(1):183. PubMed ID: 31053148
    [Abstract] [Full Text] [Related]

  • 10. Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma.
    Shao YY, Chen PS, Lin LI, Lee BS, Ling A, Cheng AL, Hsu C, Ou DL.
    Br J Cancer; 2022 Jun 03; 126(12):1806-1814. PubMed ID: 35236936
    [Abstract] [Full Text] [Related]

  • 11. The lncRNA lnc-TSI antagonizes sorafenib resistance in hepatocellular carcinoma via downregulating miR-4726-5p expression and upregulating KCNMA1 expression.
    Chen F, Jiang J, Liu D, Li H, Dong L, Song Y, Zhang Y, Wang J, Qin Y, Zhao G.
    J Mol Histol; 2024 Feb 03; 55(1):83-96. PubMed ID: 38165571
    [Abstract] [Full Text] [Related]

  • 12. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
    Wang G, Zhao W, Wang H, Qiu G, Jiang Z, Wei G, Li X.
    Med Sci Monit; 2019 Sep 25; 25():7209-7217. PubMed ID: 31553714
    [Abstract] [Full Text] [Related]

  • 13. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X.
    Oncotarget; 2015 Oct 06; 6(30):28867-81. PubMed ID: 26311740
    [Abstract] [Full Text] [Related]

  • 14. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
    Guo XL, Wang HB, Yong JK, Zhong J, Li QH.
    Eur Rev Med Pharmacol Sci; 2018 Oct 06; 22(20):6667-6677. PubMed ID: 30402839
    [Abstract] [Full Text] [Related]

  • 15. miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.
    de la Cruz-Ojeda P, Schmid T, Boix L, Moreno M, Sapena V, Praena-Fernández JM, Castell FJ, Falcón-Pérez JM, Reig M, Brüne B, Gómez-Bravo MA, Giráldez Á, Bruix J, Ferrer MT, Muntané J.
    Cells; 2022 Aug 28; 11(17):. PubMed ID: 36078082
    [Abstract] [Full Text] [Related]

  • 16. MiR-25 enhances autophagy and promotes sorafenib resistance of hepatocellular carcinoma via targeting FBXW7.
    Feng X, Zou B, Nan T, Zheng X, Zheng L, Lan J, Chen W, Yu J.
    Int J Med Sci; 2022 Aug 28; 19(2):257-266. PubMed ID: 35165511
    [Abstract] [Full Text] [Related]

  • 17. miR-23b-3p Plays an Oncogenic Role in Hepatocellular Carcinoma.
    Hayashi M, Yamada S, Kurimoto K, Tanabe H, Hirabayashi S, Sonohara F, Inokawa Y, Takami H, Kanda M, Tanaka C, Nakayama G, Koike M, Kodera Y.
    Ann Surg Oncol; 2021 Jun 28; 28(6):3416-3426. PubMed ID: 33140250
    [Abstract] [Full Text] [Related]

  • 18. miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR.
    Ji L, Lin Z, Wan Z, Xia S, Jiang S, Cen D, Cai L, Xu J, Cai X.
    Cell Death Dis; 2020 Apr 20; 11(4):250. PubMed ID: 32313144
    [Abstract] [Full Text] [Related]

  • 19. TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma.
    Lai HH, Li CW, Hong CC, Sun HY, Chiu CF, Ou DL, Chen PS.
    Mol Oncol; 2019 Apr 20; 13(4):928-945. PubMed ID: 30657254
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.